Pancreatic Cancer Research

ResearcherUniversity of GeorgiaNo recent work listed

Hardik R. Mody

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-6359-9462; OpenAlex author ID A5110967787. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 2 papers

Papers 5

  1. miR-202 Diminishes TGFβ Receptors and Attenuates TGFβ1-Induced EMT in Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-16-0327↗
  2. SET contributes to the epithelial-mesenchymal transition of pancreatic cancer. Co-author DOI 10.18632/oncotarget.19067↗
  3. Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and… Co-author DOI 10.1158/1541-7786.mcr-16-0083↗
  4. Pharmacological reversal of histone methylation presensitizes pancreatic cancer cells to nucleoside drugs: in vitro optimization and novel nanoparticle deliver… First author DOI 10.1371/journal.pone.0071196↗
  5. Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge. First author DOI 10.1016/j.canlet.2012.03.007↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sau Wai Hung · 5 shared papers, 2012–2017 · strength 0.31
  2. Rajgopal Govindarajan · 5 shared papers, 2012–2017 · strength 0.31
  3. Zobeida Cruz‐Monserrate · 1 shared paper, 2017 · strength 0.08
  4. Yangzom Doma Bhutia · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.